AAFP Updates Recommendations on Pharmacologic Management of Atrial Fibrillation

June 26, 2017 | Strategic Insights for Ambulatory Care


​The American Academy of Family Physicians (AAFP) has updated its guidance on treating atrial fibrillation with pharmacologic therapy. Atrial fibrillation is one of the most common arrhythmias in adults, and its incidence is expected to increase as the U.S. population ages, says AAFP. The updated guidance focuses on five key recommendations, including the following: 1) heart rate control is preferred over rhythm control for most patients with atrial fibrillation (AAFP states that "preferred options for rate control therapy include non-dihydropyridine calcium channel blockers and beta blockers.");

Access Full Content

Contact us today at 610.825.6000.